Yahoo
    Oslo - Delayed Quote NOK

    Bruton Limited (BRUT.OL)

    57.00 0.00 (0.00%)
    At close: November 2 at 4:27:48 PM GMT+1
    Loading Chart for BRUT.OL
    Chart Range Bar
    Interval:
    In partnership with ChartIQ

    Recent News

    International Seaways Expands VLCC Fleet Through Strategic Combination with Bruton Limited.

    International Seaways Expands VLCC Fleet Through Strategic Combination with Bruton Limited.
    Business Wire 23d ago
    International Seaways Reports Preliminary Q3 Net Income, Revenue; Plans Acquisition of Bruton

    International Seaways Reports Preliminary Q3 Net Income, Revenue; Plans Acquisition of Bruton
    PREMIUM
    MT Newswires 23d ago
    Is International Seaways (INSW) Still Worth A Look As Its Bruton Deal Tests Valuation?

    Is International Seaways (INSW) Still Worth A Look As Its Bruton Deal Tests Valuation?
    Simply Wall St. 21d ago
    3 Tanker Stocks In Focus As Oil Shipping Risk Returns

    3 Tanker Stocks In Focus As Oil Shipping Risk Returns
    Simply Wall St. 14d ago
    3 Tanker Stocks Investors Are Watching As Thin Oil Inventories Lift Shipping Rates

    3 Tanker Stocks Investors Are Watching As Thin Oil Inventories Lift Shipping Rates
    Simply Wall St. 1mo ago
    Here's Why You Should Add NRIX Stock to Your Portfolio Now

    Here's Why You Should Add NRIX Stock to Your Portfolio Now
    Zacks 1mo ago
    Roche and Nurix strike $2.3 billion blood cancer drug deal

    Roche and Nurix strike $2.3 billion blood cancer drug deal
    Quartz 4mo ago
    NRIX Stock Surges Nearly 70% Premarket Today – Roche And Nurix’s Blood Cancer Drug Collaboration Can Tap A $41B Market

    NRIX Stock Surges Nearly 70% Premarket Today – Roche And Nurix’s Blood Cancer Drug Collaboration Can Tap A $41B Market
    Stocktwits 4mo ago
    Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting

    Nurix Therapeutics Presents New Preclinical and Phase 1 Translational Data Supporting Bexobrutideg (NX-5948) in Chronic Spontaneous Urticaria at the 2026 Society for Investigative Dermatology Annual Meeting
    GlobeNewswire 5mo ago
    Curis Provides First Quarter 2026 Business Update

    Curis Provides First Quarter 2026 Business Update
    PR Newswire 5mo ago
    International Seaways Reports Third Quarter 2026 Results

    International Seaways Reports Third Quarter 2026 Results
    Business Wire 3d ago

    Related Tickers

    Mobilize your Website
    View Site in Mobile | Classic
    Share by: